Explore
Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
0 Ungluers have
Faved this Work
Login to Fave
The Special Issue of Biomedicines, entitled “Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases,” presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease pathogenesis, diagnostic advancements, novel therapeutic approaches, and prevention strategies. The Special Issue comprises seven original articles and four review articles regarding NAFLD, primary biliary cholangitis (PBC), hepatitis B and C, and hepatocellular carcinoma (HCC).
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 51 times via unglue.it ebook links.
- 51 - pdf (CC BY) at Unglue.it.
Keywords
- AAV
- Autoantibodies
- biomarker
- budesonide
- cholestatic diseases
- chronic hepatitis B
- cirrhosis
- DAA
- deletions
- farnesoid X receptor
- fatty liver
- Females
- fibrates
- fibrosis score
- FXR agonists
- gender
- Gene Therapy
- genotoxicity
- glycoprotein gp210
- HBX 3′ end region
- HCV
- hepatic steatosis
- hepatitis B virus
- hepatitis B X open reading frame
- hepatocellular carcinoma
- insertions
- KLHL12 peptide
- Liver
- liver fibrosis
- medicine
- Metabolism
- miR-125b
- Mitochondria
- n/a
- NAFLD
- NASH
- next-generation sequencing
- non-alcoholic fatty liver disease
- nucleoporin p62
- nucleos(t)ide analogs
- obeticholic acid
- obeticholic acid (OCA)
- PBC
- PFIC
- PPAR agonists
- primary biliary cholangitis
- quasispecies
- radiofrequency ablation
- RUNX1
- side effect
- Systems Biology
- transarterial chemoembolization
- transient hepatic elastography
- type 2 diabetes mellitus
- ursodeoxycholic acid
- ursodeoxycholic acid (UDCA)